Mirjam Tariverdian

1.2k total citations
16 papers, 885 citations indexed

About

Mirjam Tariverdian is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mirjam Tariverdian has authored 16 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mirjam Tariverdian's work include Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Screening and Detection (4 papers). Mirjam Tariverdian is often cited by papers focused on Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (6 papers) and Colorectal Cancer Screening and Detection (4 papers). Mirjam Tariverdian collaborates with scholars based in Germany, Netherlands and United States. Mirjam Tariverdian's co-authors include Matthias Kloor, Magnus von Knebel Doeberitz, Axel Benner, Peter Kienle, Yvette Schwitalle, H. P. Knaebel, Michael Linnebacher, Sara Michel, Miriam Reuschenbach and Niels Grabe and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Mirjam Tariverdian

15 papers receiving 869 citations

Peers

Countries citing papers authored by Mirjam Tariverdian

Since Specialization

Citations

This map shows the geographic impact of Mirjam Tariverdian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Tariverdian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Tariverdian more than expected).

Fields of papers citing papers by Mirjam Tariverdian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Tariverdian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Tariverdian. The network helps show where Mirjam Tariverdian may publish in the future.

Co-authorship network of co-authors of Mirjam Tariverdian

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Tariverdian. A scholar is included among the top collaborators of Mirjam Tariverdian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Tariverdian. Mirjam Tariverdian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial 2020 ·Clinical Cancer Research ·Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, (unknown), Salah‐Eddin Al‐Batran, Mirjam Tariverdian, Elke Jäger, Magnus von Knebel Doeberitz	92
2	Abstract A006: Frameshift peptide neoantigens as vaccine targets in microsatellite-unstable cancers 2016 ·Cancer Immunology Research ·Magnus von Knebel Doeberitz, Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, (unknown), (unknown), Julia Karbach, Mirjam Tariverdian, E. Jaeger	1
3	Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome – Molecular Alterations and Association with Clinical Parameters 2015 ·PLoS ONE ·(unknown), Fabian Echterdiek, (unknown), Axel Benner, Wiebke Werft, Bernd Lahrmann, Niels Grabe, Martin Schneider, Mirjam Tariverdian, Magnus von Knebel Doeberitz, Hendrik Bläker, Matthias Kloor	49
4	Low density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer 2015 ·OncoImmunology ·Fabian Echterdiek, (unknown), (unknown), Meike Müller, Bernd Lahrmann, (unknown), (unknown), (unknown), Axel Benner, Mirjam Tariverdian, Magnus von Knebel Doeberitz, Niels Grabe, Matthias Kloor	22
5	T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer 2012 ·Cancer Immunology Immunotherapy ·K. H. Bauer, (unknown), Miriam Reuschenbach, Moritz Koch, Jürgen Weitz, Gunnar Steinert, Jürgen Kopitz, Philipp Beckhove, Mirjam Tariverdian, Magnus von Knebel Doeberitz, Matthias Kloor	39
6	The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors 2012 ·Modern Pathology ·(unknown), Matthias Kloor, Anita Y. Voigt, (unknown), Christina Evers, Harald Gaspar, Mirjam Tariverdian, Peter Schirmacher, Magnus von Knebel Doeberitz, Hendrik Bläker	44
7	Hereditäres kolorektales Karzinom 2011 ·Der Onkologe ·Martina Kadmon, Matthias Kloor, Mirjam Tariverdian	0
8	Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome 2009 ·Familial Cancer ·Miriam Reuschenbach, Matthias Kloor, Monika Morak, Nicolas Wentzensen, Anja Germann, Yvette Garbe, Mirjam Tariverdian, Peter Findeisen, Michael Neumaier, Elke Holinski‐Feder, Magnus von Knebel Doeberitz	44
9	Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch–anal anastomosis in patients with ulcerative colitis 2009 ·Langenbeck s Archives of Surgery ·Christine Leowardi, Ulf Hinz, Mirjam Tariverdian, Peter Kienle, Christian Herfarth, Alexis Ulrich, Martina Kadmon	61
10	Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers 2008 ·Gastroenterology ·Yvette Schwitalle, Matthias Kloor, (unknown), Michael Linnebacher, Peter Kienle, H. P. Knaebel, Mirjam Tariverdian, Axel Benner, Magnus von Knebel Doeberitz	288
11	High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability 2008 ·British Journal of Cancer ·Sara Michel, Axel Benner, Mirjam Tariverdian, Nicolas Wentzensen, (unknown), Thora Pommerencke, Niels Grabe, Magnus von Knebel Doeberitz, Matthias Kloor	106
12	Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members 2008 ·Clinical Genetics ·Monika Keller, (unknown), (unknown), Heribert Sattel, (unknown), Uwe Bertsch, Friedrich W. Cremer, P. Kienle, Mirjam Tariverdian, Matthias Kloor, Johannes Gebert, Anette Brechtel	22
13	Quality of life after restorative proctocolectomy for ulcerative colitis: Preoperative status and long-term results 2007 ·Inflammatory Bowel Diseases ·Mirjam Tariverdian, Christine Leowardi, Ulf Hinz, Thilo Welsch, Jan Schmidt, Peter Kienle	20
14	Beta2‐microglobulin mutations in microsatellite unstable colorectal tumors 2007 ·International Journal of Cancer ·Matthias Kloor, Sara Michel, (unknown), Josef Rüschoff, Reinhard Büttner, Elke Holinski‐Feder, Wolfgang Dippold, Rudolf Wagner, Mirjam Tariverdian, Axel Benner, Yvette Schwitalle, (unknown), Magnus von Knebel Doeberitz	90
15	Die Bestimmung der Kollagenpeptidase-Aktivität als Parameter des Therapieeffektes bei der Sarkoidose^* 1973 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown), Karl Wurm, (unknown), Mirjam Tariverdian	2
16	[Collagen peptidase as a measure of collagen turnover in sarcoidosis]. 1973 ·PubMed ·(unknown), (unknown), Karl Wurm, Mirjam Tariverdian	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact